Literature DB >> 17262713

Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission.

Edward J Fuchs1, Linda A Lee, Michael S Torbenson, Teresa L Parsons, Rahul P Bakshi, Anita M Guidos, Richard L Wahl, Craig W Hendrix.   

Abstract

BACKGROUND: Many sexual lubricants are hyperosmolar. Hyperosmolar enemas induce epithelial damage, and enema use has been associated with an increased risk of HIV infection. To inform the development of rectal microbicide formulation, we evaluated the effects of hyperosmolar gels on the rectal mucosa.
METHODS: Two commercial lubricants were compounded into iso-osmolar and hyperosmolar mixtures (283 and 3429 mOsm/kg, respectively). Each gel was radiolabeled with 500 micro Ci of (99m)Technetium-diethylene triaminepentaacetic acid, and 10 mL was given rectally to 10 subjects in random sequence. Sigmoidoscopy by an endoscopist blinded to treatment assignment was performed 90 min later to obtain luminal and mucosal samples. Urine radiolabel detection was used to assess mucosal permeability.
RESULTS: Epithelial denudation 10 cm from the anus occurred to a greater degree with the hyperosmolar gel than with the iso-osmolar formulation (median toxicity grade, 2.50 vs. 1.17 out of 3, respectively; P=.009). The hyperosmolar gel was also associated with lower isotope luminal concentration at 10 cm, compared with the iso-osmolar gel (median, 8.9% vs. 54.6% of administered concentration, respectively). Mucosal permeability measured through 12 h was reduced with the hyperosmolar gel (P=.037).
CONCLUSION: Rectally applied hyperosmolar gels induce greater epithelial denudation and luminal secretion than iso-osmolar gels. Because denudation plausibly increases the risk of HIV transmission, hyperosmolar gels make poor rectal microbicide formulations, and hyperosmolar sexual lubricants may increase susceptibility to HIV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17262713     DOI: 10.1086/511279

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  79 in total

1.  Distribution of cell-free and cell-associated HIV surrogates in the colon after simulated receptive anal intercourse in men who have sex with men.

Authors:  Nicolette A Louissaint; Sridhar Nimmagadda; Edward J Fuchs; Rahul P Bakshi; Ying-Jun Cao; Linda A Lee; Jeff Goldsmith; Brian S Caffo; Yong Du; Karen E King; Frederick A Menendez; Michael S Torbenson; Craig W Hendrix
Journal:  J Acquir Immune Defic Syndr       Date:  2012-01-01       Impact factor: 3.731

2.  Reformulated tenofovir gel for use as a dual compartment microbicide.

Authors:  Charlene S Dezzutti; Lisa C Rohan; Lin Wang; Kevin Uranker; Cory Shetler; Marilyn Cost; J D Lynam; David Friend
Journal:  J Antimicrob Chemother       Date:  2012-05-11       Impact factor: 5.790

3.  Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV Infection.

Authors:  Peng Xiao; Sanjeev Gumber; Mark A Marzinke; Abhijit A Date; Thuy Hoang; Justin Hanes; Laura M Ensign; Lin Wang; Lisa Rohan; Edward J Fuchs; Craig Hendrix; Francois Villinger
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

4.  Topical injury evaluation of the murine colorectal mucosa using confocal endomicrosopy: a valuable method for assessing mucosal injuries associated with risk of pathogen transmission.

Authors:  Gracie Vargas; Kathleen Listiak Vincent; Jingna Wei; Nigel Bourne; Massoud Motamedi
Journal:  J Microsc       Date:  2016-06-28       Impact factor: 1.758

5.  Enema ion compositions for enhancing colorectal drug delivery.

Authors:  Katharina Maisel; Sumon Chattopadhyay; Thomas Moench; Craig Hendrix; Richard Cone; Laura M Ensign; Justin Hanes
Journal:  J Control Release       Date:  2015-04-30       Impact factor: 9.776

Review 6.  Rectal microbicide development.

Authors:  Ian McGowan
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

7.  Quantitative assessment of altered rectal mucosal permeability due to rectally applied nonoxynol-9, biopsy, and simulated intercourse.

Authors:  Edward J Fuchs; Lisa A Grohskopf; Linda A Lee; Rahul P Bakshi; Craig W Hendrix
Journal:  J Infect Dis       Date:  2013-01-16       Impact factor: 5.226

Review 8.  Rectal microbicide development.

Authors:  Ian McGowan; Charlene Dezzutti
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

9.  In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.

Authors:  Lisa C Rohan; Bernard J Moncla; Ratiya Pamela Kunjara Na Ayudhya; Marilyn Cost; Yunda Huang; Fang Gai; Nicole Billitto; J D Lynam; Kara Pryke; Phillip Graebing; Nicole Hopkins; James F Rooney; David Friend; Charlene S Dezzutti
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

10.  Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse.

Authors:  Thomas R Moench; Russell J Mumper; Timothy E Hoen; Mianmian Sun; Richard A Cone
Journal:  BMC Infect Dis       Date:  2010-11-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.